Hyperpigmentation disorders are skin conditions identified by darkened skin areas. The types include melasma, post-inflammatory hyperpigmentation, and age spots. Hyperpigmentation takes place when the skin creates more melanin. This can cause patches or spots of skin look darker than surrounding areas. It is usually harmless but can often be triggered by a fundamental medical condition. Certain medications can also cause skin darkening.
The “hyperpigmentation disorders treatment Market was projected to generate a market value of USD 3,915 million globally. It is likely to develop at a CAGR of 7.1% over the forecast period”.
Dermabrasion procedures include augmented adoption of lasers in pigmentation disorders treatment and growing expenditure on the cosmetics across the world are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by the top players such as new product launches are contributing to the growth of the market. According to the American Society of Plastic Surgeons, the number of dermabrasion cosmetic procedures have increased from 42,218 in 2000 to 88,182 in 2016 with a 109% increase during the estimated period.
Avail Free Sample at https://www.marketresearchfuture.com/sample_request/7462
- Medical devices manufacturers
- Pharmaceutical Companies
- Medical devices product distributors and suppliers
- Healthcare providers
- Research institutes and academic centers
- Government associations
- Market research and consulting
The worldwide hyperpigmentation disorders treatment market has been segmented based on disease indication, treatment type, and end-user.
Based on disease indication, the hyperpigmentation disorders treatment market has been segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others.
Based on treatment type, the market has been segmented as microdermabrasion, topical drugs, chemical peels, phototherapy, laser therapy, and others. Over the forecast period, the topical drugs segment is likely to hold a major market share for the hyperpigmentation disorders treatment.
Based on end-user, the market has been segmented into aesthetic clinics, dermatology centers, hospitals, and others.
Top Key Players
Following are Some of the key players in the global hyperpigmentation disorders treatment market are, Allergan, Inc., Bayer AG, EpiPharm AG, Episciences, Inc., Galderma laboratories (Nestle Skin Health S.A), Obagi Cosmeceuticals LLC, Pierre Fabre, RXi Pharmaceuticals Corporation, SkinCeuticals International, and Vivier Pharma.
Access Complete Premium Research Report at https://www.marketresearchfuture.com/reports/hyperpigmentation-disorders-treatment-market-7462
Geographically, the market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
Chapter 9. Global Hyperpigmentation Disorders Treatment Market, By Region
9.2.1 North America
9.2.2 South America
9.3.1 Western Europe
184.108.40.206 Rest Of Western Europe
9.3.2 Eastern Europe
9.4.5 South Korea
9.4.6 Rest Of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
Get an Amazing Discount at https://www.marketresearchfuture.com/check-discount/7462
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar